This document summarizes information about the drug Albendazole. It begins with an introduction stating that Albendazole is a broad-spectrum anthelmintic drug developed in 1975 that is used to treat various helminth infections. It then covers Albendazole's chemistry, pharmacokinetics, mechanism of action, clinical indications, adverse effects, contraindications, and drug interactions. The key points are that Albendazole is a benzimidazole carbamate derivative that is metabolized in the liver and excreted in bile. It works by inhibiting helminth microtubule polymerization. Its clinical uses include treatment of ascariasis, cysticercosis, and other nematode